SCHEMBL5761776

SCHEMBL5761776

COc1ccc2nc([S+]([O-])Cc3ncc(C)c(OC)c3C)n(S(=O)(=O)c3ccc(OC)c(C(=O)O)c3)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.41
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 3/20 0.37
WDR5 P61964 2/20 0.37
BRS3 P32247 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ATP1A1 P05023 2/20 0.37
ATP1B1 P05026 2/20 0.37
ATP1A3 P13637 2/20 0.37
ATP1B2 P14415 2/20 0.37
HPGD P15428 2/20 0.37
ATP4A P20648 2/20 0.37
ATP1A2 P50993 2/20 0.37
ATP4B P51164 2/20 0.37
ATP1B3 P54709 2/20 0.37
FXYD2 P54710 2/20 0.37
ATP1A4 Q13733 2/20 0.37
HTT P42858 2/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5761022 1.00 CYP2C9 (0.41) CYP2C9KMT2AALDH1A1HSD17B10WDR5
SCHEMBL5760989 0.99 CYP2C9 (0.40) CYP2C9KMT2AALDH1A1HSD17B10WDR5
SCHEMBL5761001 0.95 CYP2C9 (0.41) CYP2C9KMT2AALDH1A1HSD17B10WDR5
SCHEMBL5763843 0.94 CYP2C9 (0.39) CYP2C9KMT2AALDH1A1HSD17B10WDR5
SCHEMBL5763970 0.94 CYP2C9 (0.39) CYP2C9KMT2AALDH1A1HSD17B10WDR5
SCHEMBL5763833 0.94 CYP2C9 (0.38) CYP2C9KMT2AALDH1A1HSD17B10WDR5
SCHEMBL5763949 0.93 CYP2C9 (0.39) CYP2C9KMT2AALDH1A1HSD17B10WDR5
SCHEMBL5763839 0.89 CYP2C9 (0.39) CYP2C9KMT2AALDH1A1HSD17B10WDR5
SCHEMBL5763690 0.89 CYP2C9 (0.40) CYP2C9KMT2AALDH1A1HSD17B10WDR5
SCHEMBL5763954 0.89 CYP2C9 (0.40) CYP2C9KMT2AALDH1A1HSD17B10WDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556371-B1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PRODRUGS OF PROTON PUMP INHIBITOR WINSTON PHARMACEUTICALS LLC (US) 2006-04-19 EP disclosed